nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Citrulline—NOS1—epilepsy syndrome	0.276	0.656	CbGaD
L-Citrulline—Carglumic Acid—Vigabatrin—epilepsy syndrome	0.252	0.601	CrCrCtD
L-Citrulline—L-Glutamine—Vigabatrin—epilepsy syndrome	0.168	0.399	CrCrCtD
L-Citrulline—NOS2—epilepsy syndrome	0.145	0.344	CbGaD
L-Citrulline—NOS1—ganglion—epilepsy syndrome	0.00234	0.0398	CbGeAlD
L-Citrulline—PADI2—forebrain—epilepsy syndrome	0.00182	0.0309	CbGeAlD
L-Citrulline—PADI1—head—epilepsy syndrome	0.00179	0.0304	CbGeAlD
L-Citrulline—NOS1—hindbrain—epilepsy syndrome	0.00178	0.0302	CbGeAlD
L-Citrulline—PADI2—telencephalon—epilepsy syndrome	0.00167	0.0284	CbGeAlD
L-Citrulline—PADI3—head—epilepsy syndrome	0.00149	0.0254	CbGeAlD
L-Citrulline—DDAH1—forebrain—epilepsy syndrome	0.00147	0.025	CbGeAlD
L-Citrulline—PADI3—nervous system—epilepsy syndrome	0.00141	0.0241	CbGeAlD
L-Citrulline—PADI4—head—epilepsy syndrome	0.0014	0.0237	CbGeAlD
L-Citrulline—PADI3—central nervous system—epilepsy syndrome	0.00136	0.0232	CbGeAlD
L-Citrulline—DDAH1—telencephalon—epilepsy syndrome	0.00135	0.023	CbGeAlD
L-Citrulline—PADI4—nervous system—epilepsy syndrome	0.00132	0.0225	CbGeAlD
L-Citrulline—PADI4—central nervous system—epilepsy syndrome	0.00127	0.0217	CbGeAlD
L-Citrulline—OTC—head—epilepsy syndrome	0.00123	0.0208	CbGeAlD
L-Citrulline—PADI2—midbrain—epilepsy syndrome	0.0012	0.0204	CbGeAlD
L-Citrulline—PADI2—spinal cord—epilepsy syndrome	0.00117	0.0199	CbGeAlD
L-Citrulline—OTC—nervous system—epilepsy syndrome	0.00116	0.0198	CbGeAlD
L-Citrulline—DDAH1—Bortezomib—Lacosamide—epilepsy syndrome	0.00113	0.501	CbGdCrCtD
L-Citrulline—ASS1—Protriptyline—Carbamazepine—epilepsy syndrome	0.00112	0.499	CbGdCrCtD
L-Citrulline—OTC—central nervous system—epilepsy syndrome	0.00112	0.019	CbGeAlD
L-Citrulline—DDAH2—medulla oblongata—epilepsy syndrome	0.0011	0.0187	CbGeAlD
L-Citrulline—PADI3—brain—epilepsy syndrome	0.00108	0.0184	CbGeAlD
L-Citrulline—PADI2—head—epilepsy syndrome	0.00104	0.0177	CbGeAlD
L-Citrulline—NOS1—brainstem—epilepsy syndrome	0.00102	0.0173	CbGeAlD
L-Citrulline—PADI4—brain—epilepsy syndrome	0.00101	0.0172	CbGeAlD
L-Citrulline—DDAH2—midbrain—epilepsy syndrome	0.00101	0.0171	CbGeAlD
L-Citrulline—PADI2—nervous system—epilepsy syndrome	0.000988	0.0168	CbGeAlD
L-Citrulline—NOS1—forebrain—epilepsy syndrome	0.000982	0.0167	CbGeAlD
L-Citrulline—DDAH2—spinal cord—epilepsy syndrome	0.000982	0.0167	CbGeAlD
L-Citrulline—DDAH1—midbrain—epilepsy syndrome	0.000971	0.0165	CbGeAlD
L-Citrulline—PADI2—central nervous system—epilepsy syndrome	0.000951	0.0162	CbGeAlD
L-Citrulline—DDAH1—spinal cord—epilepsy syndrome	0.000947	0.0161	CbGeAlD
L-Citrulline—PADI2—cerebellum—epilepsy syndrome	0.000929	0.0158	CbGeAlD
L-Citrulline—NOS1—telencephalon—epilepsy syndrome	0.000903	0.0154	CbGeAlD
L-Citrulline—OTC—brain—epilepsy syndrome	0.000888	0.0151	CbGeAlD
L-Citrulline—DDAH1—head—epilepsy syndrome	0.000842	0.0143	CbGeAlD
L-Citrulline—DDAH1—nervous system—epilepsy syndrome	0.000798	0.0136	CbGeAlD
L-Citrulline—DDAH2—cerebellum—epilepsy syndrome	0.000779	0.0132	CbGeAlD
L-Citrulline—L-Glutamine—QARS—epilepsy syndrome	0.000769	0.239	CrCbGaD
L-Citrulline—DDAH1—central nervous system—epilepsy syndrome	0.000768	0.0131	CbGeAlD
L-Citrulline—PADI2—brain—epilepsy syndrome	0.000755	0.0128	CbGeAlD
L-Citrulline—DDAH1—cerebellum—epilepsy syndrome	0.000751	0.0128	CbGeAlD
L-Citrulline—ASS1—forebrain—epilepsy syndrome	0.000749	0.0127	CbGeAlD
L-Citrulline—NOS3—forebrain—epilepsy syndrome	0.000747	0.0127	CbGeAlD
L-Citrulline—NOS1—medulla oblongata—epilepsy syndrome	0.00071	0.0121	CbGeAlD
L-Citrulline—ASS1—telencephalon—epilepsy syndrome	0.000689	0.0117	CbGeAlD
L-Citrulline—NOS3—telencephalon—epilepsy syndrome	0.000687	0.0117	CbGeAlD
L-Citrulline—L-Aspartic Acid—SLC1A1—epilepsy syndrome	0.000653	0.203	CrCbGaD
L-Citrulline—NOS1—spinal cord—epilepsy syndrome	0.000633	0.0108	CbGeAlD
L-Citrulline—DDAH2—brain—epilepsy syndrome	0.000633	0.0108	CbGeAlD
L-Citrulline—DDAH1—brain—epilepsy syndrome	0.00061	0.0104	CbGeAlD
L-Citrulline—NOS1—head—epilepsy syndrome	0.000563	0.00957	CbGeAlD
L-Citrulline—ASS1—medulla oblongata—epilepsy syndrome	0.000541	0.00921	CbGeAlD
L-Citrulline—NOS1—nervous system—epilepsy syndrome	0.000533	0.00907	CbGeAlD
L-Citrulline—L-Methionine—GLUL—epilepsy syndrome	0.000516	0.16	CrCbGaD
L-Citrulline—NOS1—central nervous system—epilepsy syndrome	0.000513	0.00873	CbGeAlD
L-Citrulline—Glutathione—GPX1—epilepsy syndrome	0.000505	0.157	CrCbGaD
L-Citrulline—NOS1—cerebellum—epilepsy syndrome	0.000502	0.00853	CbGeAlD
L-Citrulline—ASS1—midbrain—epilepsy syndrome	0.000495	0.00841	CbGeAlD
L-Citrulline—ASS1—spinal cord—epilepsy syndrome	0.000483	0.00821	CbGeAlD
L-Citrulline—ASS1—head—epilepsy syndrome	0.000429	0.0073	CbGeAlD
L-Citrulline—NOS3—head—epilepsy syndrome	0.000428	0.00727	CbGeAlD
L-Citrulline—NOS1—brain—epilepsy syndrome	0.000408	0.00693	CbGeAlD
L-Citrulline—ASS1—nervous system—epilepsy syndrome	0.000407	0.00692	CbGeAlD
L-Citrulline—NOS3—nervous system—epilepsy syndrome	0.000405	0.0069	CbGeAlD
L-Citrulline—ASS1—central nervous system—epilepsy syndrome	0.000392	0.00666	CbGeAlD
L-Citrulline—NOS3—central nervous system—epilepsy syndrome	0.00039	0.00664	CbGeAlD
L-Citrulline—ASS1—cerebellum—epilepsy syndrome	0.000383	0.00651	CbGeAlD
L-Citrulline—L-Glutamine—GLUL—epilepsy syndrome	0.000376	0.117	CrCbGaD
L-Citrulline—ASS1—brain—epilepsy syndrome	0.000311	0.00529	CbGeAlD
L-Citrulline—NOS3—brain—epilepsy syndrome	0.00031	0.00527	CbGeAlD
L-Citrulline—L-Arginine—NOS2—epilepsy syndrome	0.000262	0.0814	CrCbGaD
L-Citrulline—Glutathione—ABCC2—epilepsy syndrome	0.000138	0.0428	CrCbGaD
L-Citrulline—ASS1—Metabolism—CYP2D6—epilepsy syndrome	2.21e-05	0.000235	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—PRKCB—epilepsy syndrome	2.18e-05	0.000231	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—ACKR4—epilepsy syndrome	2.18e-05	0.000231	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—HSD17B4—epilepsy syndrome	2.17e-05	0.00023	CbGpPWpGaD
L-Citrulline—NOS3—Myometrial Relaxation and Contraction Pathways—JUN—epilepsy syndrome	2.16e-05	0.000229	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—NOS2—epilepsy syndrome	2.15e-05	0.000228	CbGpPWpGaD
L-Citrulline—NOS3—Leptin signaling pathway—AKT1—epilepsy syndrome	2.15e-05	0.000228	CbGpPWpGaD
L-Citrulline—OTC—Metabolism—GPX1—epilepsy syndrome	2.12e-05	0.000225	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—NOS1—epilepsy syndrome	2.12e-05	0.000224	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—ADRA2A—epilepsy syndrome	2.11e-05	0.000223	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—BCHE—epilepsy syndrome	2.1e-05	0.000222	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—PPP1R3C—epilepsy syndrome	2.1e-05	0.000222	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—GBE1—epilepsy syndrome	2.1e-05	0.000222	CbGpPWpGaD
L-Citrulline—NOS3—Disease—ST3GAL3—epilepsy syndrome	2.08e-05	0.000221	CbGpPWpGaD
L-Citrulline—NOS3—EGF/EGFR Signaling Pathway—JUN—epilepsy syndrome	2.08e-05	0.000221	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—FYN—epilepsy syndrome	2.07e-05	0.00022	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—SLC2A1—epilepsy syndrome	2e-05	0.000212	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—YWHAZ—epilepsy syndrome	1.99e-05	0.000211	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—AKT3—epilepsy syndrome	1.98e-05	0.00021	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—PLCB1—epilepsy syndrome	1.98e-05	0.00021	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—ASAH1—epilepsy syndrome	1.97e-05	0.000209	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—TH—epilepsy syndrome	1.97e-05	0.000209	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—SSTR4—epilepsy syndrome	1.97e-05	0.000209	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—SSTR5—epilepsy syndrome	1.97e-05	0.000209	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—PLAUR—epilepsy syndrome	1.96e-05	0.000208	CbGpPWpGaD
L-Citrulline—NOS2—Disease—EIF2AK2—epilepsy syndrome	1.95e-05	0.000207	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—STXBP1—epilepsy syndrome	1.92e-05	0.000203	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CCR10—epilepsy syndrome	1.89e-05	0.0002	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—NT5E—epilepsy syndrome	1.87e-05	0.000198	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—ALAD—epilepsy syndrome	1.87e-05	0.000198	CbGpPWpGaD
L-Citrulline—NOS3—EGF/EGFR Signaling Pathway—SRC—epilepsy syndrome	1.87e-05	0.000198	CbGpPWpGaD
L-Citrulline—OTC—Metabolism—AGT—epilepsy syndrome	1.86e-05	0.000197	CbGpPWpGaD
L-Citrulline—NOS3—Corticotropin-releasing hormone—AKT1—epilepsy syndrome	1.82e-05	0.000193	CbGpPWpGaD
L-Citrulline—OTC—Metabolism—APOE—epilepsy syndrome	1.82e-05	0.000193	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—ALB—epilepsy syndrome	1.81e-05	0.000192	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—CDC42—epilepsy syndrome	1.81e-05	0.000192	CbGpPWpGaD
L-Citrulline—NOS2—Disease—PPIA—epilepsy syndrome	1.81e-05	0.000192	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—ALDH7A1—epilepsy syndrome	1.78e-05	0.000189	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—CACNA1A—epilepsy syndrome	1.78e-05	0.000189	CbGpPWpGaD
L-Citrulline—NOS1—Disease—SLC2A1—epilepsy syndrome	1.78e-05	0.000188	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—PLAU—epilepsy syndrome	1.77e-05	0.000188	CbGpPWpGaD
L-Citrulline—NOS1—Disease—JUNB—epilepsy syndrome	1.76e-05	0.000187	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—ST3GAL3—epilepsy syndrome	1.74e-05	0.000185	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—ADSL—epilepsy syndrome	1.71e-05	0.000181	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—GLUL—epilepsy syndrome	1.68e-05	0.000178	CbGpPWpGaD
L-Citrulline—NOS1—Disease—HBEGF—epilepsy syndrome	1.67e-05	0.000177	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—GRM2—epilepsy syndrome	1.65e-05	0.000175	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—HMOX1—epilepsy syndrome	1.65e-05	0.000174	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—CACNA1D—epilepsy syndrome	1.65e-05	0.000174	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—PRKCB—epilepsy syndrome	1.64e-05	0.000174	CbGpPWpGaD
L-Citrulline—NOS1—Disease—AKT3—epilepsy syndrome	1.64e-05	0.000174	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—CAT—epilepsy syndrome	1.62e-05	0.000172	CbGpPWpGaD
L-Citrulline—NOS3—VEGFA-VEGFR2 Pathway—AKT1—epilepsy syndrome	1.62e-05	0.000171	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—FYN—epilepsy syndrome	1.61e-05	0.000171	CbGpPWpGaD
L-Citrulline—NOS1—Disease—ADAM10—epilepsy syndrome	1.6e-05	0.00017	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—ABCB1—epilepsy syndrome	1.58e-05	0.000167	CbGpPWpGaD
L-Citrulline—OTC—Metabolism—POMC—epilepsy syndrome	1.56e-05	0.000166	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—YWHAZ—epilepsy syndrome	1.55e-05	0.000164	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—TXNRD1—epilepsy syndrome	1.54e-05	0.000163	CbGpPWpGaD
L-Citrulline—NOS3—Signaling by VEGF—AKT1—epilepsy syndrome	1.53e-05	0.000162	CbGpPWpGaD
L-Citrulline—NOS3—Disease—EIF2AK2—epilepsy syndrome	1.52e-05	0.000161	CbGpPWpGaD
L-Citrulline—NOS1—Disease—CDC42—epilepsy syndrome	1.49e-05	0.000159	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—AQP1—epilepsy syndrome	1.49e-05	0.000158	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—SSTR3—epilepsy syndrome	1.49e-05	0.000158	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—GPX1—epilepsy syndrome	1.47e-05	0.000156	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—ST3GAL3—epilepsy syndrome	1.46e-05	0.000155	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—ARHGEF9—epilepsy syndrome	1.43e-05	0.000152	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CCR9—epilepsy syndrome	1.43e-05	0.000152	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—NPY2R—epilepsy syndrome	1.43e-05	0.000152	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CCR8—epilepsy syndrome	1.43e-05	0.000152	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—SSTR1—epilepsy syndrome	1.43e-05	0.000152	CbGpPWpGaD
L-Citrulline—OTC—Metabolism—ALB—epilepsy syndrome	1.43e-05	0.000151	CbGpPWpGaD
L-Citrulline—NOS3—Disease—PPIA—epilepsy syndrome	1.4e-05	0.000149	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—GRM3—epilepsy syndrome	1.4e-05	0.000149	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—GRM4—epilepsy syndrome	1.4e-05	0.000149	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—DUSP4—epilepsy syndrome	1.38e-05	0.000146	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—SSTR2—epilepsy syndrome	1.38e-05	0.000146	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—PLAU—epilepsy syndrome	1.37e-05	0.000146	CbGpPWpGaD
L-Citrulline—NOS1—Disease—HES1—epilepsy syndrome	1.37e-05	0.000145	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—ALB—epilepsy syndrome	1.37e-05	0.000145	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—CHRM3—epilepsy syndrome	1.35e-05	0.000143	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—KCNJ11—epilepsy syndrome	1.35e-05	0.000143	CbGpPWpGaD
L-Citrulline—NOS2—Disease—SLC2A1—epilepsy syndrome	1.34e-05	0.000142	CbGpPWpGaD
L-Citrulline—NOS1—Disease—FYN—epilepsy syndrome	1.33e-05	0.000141	CbGpPWpGaD
L-Citrulline—NOS2—Disease—JUNB—epilepsy syndrome	1.33e-05	0.000141	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—GRM8—epilepsy syndrome	1.33e-05	0.000141	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PGF—epilepsy syndrome	1.33e-05	0.000141	CbGpPWpGaD
L-Citrulline—NOS1—Disease—H2AFX—epilepsy syndrome	1.33e-05	0.000141	CbGpPWpGaD
L-Citrulline—NOS2—Disease—NOS1—epilepsy syndrome	1.32e-05	0.00014	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—AGT—epilepsy syndrome	1.29e-05	0.000137	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—SRC—epilepsy syndrome	1.28e-05	0.000136	CbGpPWpGaD
L-Citrulline—NOS1—Disease—YWHAZ—epilepsy syndrome	1.28e-05	0.000136	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—PRKCB—epilepsy syndrome	1.28e-05	0.000135	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—GNAO1—epilepsy syndrome	1.27e-05	0.000134	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—OPRD1—epilepsy syndrome	1.27e-05	0.000134	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—NOS2—epilepsy syndrome	1.26e-05	0.000134	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—APOE—epilepsy syndrome	1.26e-05	0.000134	CbGpPWpGaD
L-Citrulline—NOS2—Disease—HBEGF—epilepsy syndrome	1.26e-05	0.000134	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—VEGFA—epilepsy syndrome	1.25e-05	0.000132	CbGpPWpGaD
L-Citrulline—OTC—Metabolism—PTGS2—epilepsy syndrome	1.25e-05	0.000132	CbGpPWpGaD
L-Citrulline—NOS2—Disease—AKT3—epilepsy syndrome	1.24e-05	0.000131	CbGpPWpGaD
L-Citrulline—NOS1—Disease—CCR5—epilepsy syndrome	1.23e-05	0.00013	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PDYN—epilepsy syndrome	1.22e-05	0.000129	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CCR7—epilepsy syndrome	1.22e-05	0.000129	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CHRM1—epilepsy syndrome	1.22e-05	0.000129	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—GRM1—epilepsy syndrome	1.22e-05	0.000129	CbGpPWpGaD
L-Citrulline—NOS2—Disease—ADAM10—epilepsy syndrome	1.21e-05	0.000128	CbGpPWpGaD
L-Citrulline—NOS3—EGF/EGFR Signaling Pathway—AKT1—epilepsy syndrome	1.16e-05	0.000123	CbGpPWpGaD
L-Citrulline—NOS1—Disease—TSC2—epilepsy syndrome	1.14e-05	0.000121	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—GAL—epilepsy syndrome	1.14e-05	0.000121	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—GFAP—epilepsy syndrome	1.14e-05	0.000121	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CASP2—epilepsy syndrome	1.13e-05	0.00012	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CHRM3—epilepsy syndrome	1.13e-05	0.00012	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—GRM5—epilepsy syndrome	1.13e-05	0.00012	CbGpPWpGaD
L-Citrulline—NOS2—Disease—CDC42—epilepsy syndrome	1.13e-05	0.00012	CbGpPWpGaD
L-Citrulline—NOS1—Disease—APOE—epilepsy syndrome	1.12e-05	0.000119	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—ABCG2—epilepsy syndrome	1.1e-05	0.000117	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—POMC—epilepsy syndrome	1.08e-05	0.000115	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CX3CR1—epilepsy syndrome	1.08e-05	0.000115	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—CYP2C19—epilepsy syndrome	1.07e-05	0.000114	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—CYP11A1—epilepsy syndrome	1.07e-05	0.000113	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CHRM2—epilepsy syndrome	1.06e-05	0.000113	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—BDKRB1—epilepsy syndrome	1.06e-05	0.000113	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CX3CL1—epilepsy syndrome	1.06e-05	0.000113	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—ALB—epilepsy syndrome	1.06e-05	0.000112	CbGpPWpGaD
L-Citrulline—NOS1—Disease—IL6ST—epilepsy syndrome	1.05e-05	0.000112	CbGpPWpGaD
L-Citrulline—NOS1—Disease—NOS2—epilepsy syndrome	1.04e-05	0.000111	CbGpPWpGaD
L-Citrulline—NOS3—Disease—SLC2A1—epilepsy syndrome	1.04e-05	0.00011	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—GABBR1—epilepsy syndrome	1.03e-05	0.00011	CbGpPWpGaD
L-Citrulline—NOS2—Disease—HES1—epilepsy syndrome	1.03e-05	0.000109	CbGpPWpGaD
L-Citrulline—NOS3—Disease—JUNB—epilepsy syndrome	1.03e-05	0.000109	CbGpPWpGaD
L-Citrulline—NOS3—Disease—NOS1—epilepsy syndrome	1.02e-05	0.000109	CbGpPWpGaD
L-Citrulline—NOS2—Disease—FYN—epilepsy syndrome	1e-05	0.000106	CbGpPWpGaD
L-Citrulline—NOS2—Disease—H2AFX—epilepsy syndrome	1e-05	0.000106	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—HRH3—epilepsy syndrome	9.91e-06	0.000105	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—ALB—epilepsy syndrome	9.88e-06	0.000105	CbGpPWpGaD
L-Citrulline—NOS3—Disease—HBEGF—epilepsy syndrome	9.78e-06	0.000104	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—OPRM1—epilepsy syndrome	9.75e-06	0.000103	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—SRC—epilepsy syndrome	9.67e-06	0.000102	CbGpPWpGaD
L-Citrulline—NOS2—Disease—YWHAZ—epilepsy syndrome	9.65e-06	0.000102	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—CYP2D6—epilepsy syndrome	9.63e-06	0.000102	CbGpPWpGaD
L-Citrulline—NOS3—Disease—AKT3—epilepsy syndrome	9.6e-06	0.000102	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—VEGFA—epilepsy syndrome	9.41e-06	9.98e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—ADAM10—epilepsy syndrome	9.37e-06	9.94e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—CCR5—epilepsy syndrome	9.28e-06	9.84e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CCR3—epilepsy syndrome	9.21e-06	9.77e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—ADRA2A—epilepsy syndrome	9.17e-06	9.72e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—BCHE—epilepsy syndrome	9.13e-06	9.68e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—NPY—epilepsy syndrome	8.98e-06	9.52e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—ATP2A2—epilepsy syndrome	8.98e-06	9.52e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—CDC42—epilepsy syndrome	8.75e-06	9.28e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—SLC2A1—epilepsy syndrome	8.71e-06	9.23e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—HSPB1—epilepsy syndrome	8.66e-06	9.18e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CRH—epilepsy syndrome	8.66e-06	9.18e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—OXT—epilepsy syndrome	8.66e-06	9.18e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CXCL2—epilepsy syndrome	8.66e-06	9.18e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CCL3—epilepsy syndrome	8.66e-06	9.18e-05	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—PTGS2—epilepsy syndrome	8.64e-06	9.17e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—TSC2—epilepsy syndrome	8.63e-06	9.15e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—PLCB1—epilepsy syndrome	8.61e-06	9.13e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—TH—epilepsy syndrome	8.58e-06	9.1e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—FGF2—epilepsy syndrome	8.5e-06	9.02e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—APOE—epilepsy syndrome	8.44e-06	8.95e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—TSC1—epilepsy syndrome	8.05e-06	8.54e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PTK2B—epilepsy syndrome	8.05e-06	8.54e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—HES1—epilepsy syndrome	8.01e-06	8.5e-05	CbGpPWpGaD
L-Citrulline—NOS1—Hemostasis—AKT1—epilepsy syndrome	7.96e-06	8.44e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—IL6ST—epilepsy syndrome	7.93e-06	8.41e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—SST—epilepsy syndrome	7.83e-06	8.3e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CCR2—epilepsy syndrome	7.83e-06	8.3e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—NTRK2—epilepsy syndrome	7.83e-06	8.3e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—FYN—epilepsy syndrome	7.79e-06	8.26e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—H2AFX—epilepsy syndrome	7.77e-06	8.23e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—DUSP6—epilepsy syndrome	7.76e-06	8.23e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—MTOR—epilepsy syndrome	7.74e-06	8.21e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—PTGS2—epilepsy syndrome	7.67e-06	8.13e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—ADRA2A—epilepsy syndrome	7.66e-06	8.13e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PLAT—epilepsy syndrome	7.63e-06	8.09e-05	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—SRC—epilepsy syndrome	7.51e-06	7.96e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—YWHAZ—epilepsy syndrome	7.49e-06	7.94e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CXCL12—epilepsy syndrome	7.36e-06	7.81e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—BDKRB2—epilepsy syndrome	7.36e-06	7.81e-05	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—VEGFA—epilepsy syndrome	7.31e-06	7.75e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—JUNB—epilepsy syndrome	7.23e-06	7.66e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CNR1—epilepsy syndrome	7.23e-06	7.66e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—CCR5—epilepsy syndrome	7.21e-06	7.64e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PLCB1—epilepsy syndrome	7.2e-06	7.64e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—HMOX1—epilepsy syndrome	7.16e-06	7.59e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—CAT—epilepsy syndrome	7.07e-06	7.49e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—HTR7—epilepsy syndrome	7.05e-06	7.48e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—ABCB1—epilepsy syndrome	6.87e-06	7.29e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—HBEGF—epilepsy syndrome	6.85e-06	7.26e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—AKT3—epilepsy syndrome	6.72e-06	7.13e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—TSC2—epilepsy syndrome	6.7e-06	7.1e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—ADAM10—epilepsy syndrome	6.56e-06	6.96e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—APOE—epilepsy syndrome	6.56e-06	6.95e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—FGF2—epilepsy syndrome	6.41e-06	6.8e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—GPX1—epilepsy syndrome	6.39e-06	6.78e-05	CbGpPWpGaD
L-Citrulline—OTC—Metabolism—AKT1—epilepsy syndrome	6.27e-06	6.65e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—S100B—epilepsy syndrome	6.21e-06	6.58e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—SRC—epilepsy syndrome	6.2e-06	6.58e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—IL6ST—epilepsy syndrome	6.16e-06	6.53e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—SOCS3—epilepsy syndrome	6.15e-06	6.52e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CDC42—epilepsy syndrome	6.13e-06	6.5e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—NOS2—epilepsy syndrome	6.11e-06	6.48e-05	CbGpPWpGaD
L-Citrulline—NOS2—Hemostasis—AKT1—epilepsy syndrome	6.01e-06	6.37e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—AVP—epilepsy syndrome	5.94e-06	6.29e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—MTOR—epilepsy syndrome	5.84e-06	6.19e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—PTGS2—epilepsy syndrome	5.79e-06	6.14e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—HES1—epilepsy syndrome	5.61e-06	5.95e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—AGT—epilepsy syndrome	5.6e-06	5.94e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—APOE—epilepsy syndrome	5.49e-06	5.82e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—FYN—epilepsy syndrome	5.46e-06	5.79e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—H2AFX—epilepsy syndrome	5.44e-06	5.77e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—MEF2C—epilepsy syndrome	5.43e-06	5.76e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—YWHAZ—epilepsy syndrome	5.25e-06	5.56e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—NGF—epilepsy syndrome	5.19e-06	5.5e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CCR5—epilepsy syndrome	5.05e-06	5.35e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—FGF2—epilepsy syndrome	4.98e-06	5.28e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—HTR2A—epilepsy syndrome	4.94e-06	5.24e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—POMC—epilepsy syndrome	4.72e-06	5e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—TSC2—epilepsy syndrome	4.69e-06	4.98e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—AGT—epilepsy syndrome	4.69e-06	4.97e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—SRC—epilepsy syndrome	4.68e-06	4.96e-05	CbGpPWpGaD
L-Citrulline—NOS3—Hemostasis—AKT1—epilepsy syndrome	4.66e-06	4.95e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—APOE—epilepsy syndrome	4.59e-06	4.87e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—MTOR—epilepsy syndrome	4.53e-06	4.81e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—KDR—epilepsy syndrome	4.5e-06	4.77e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—PTGS2—epilepsy syndrome	4.49e-06	4.76e-05	CbGpPWpGaD
L-Citrulline—ASS1—Metabolism—AKT1—epilepsy syndrome	4.34e-06	4.61e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—PRKCB—epilepsy syndrome	4.33e-06	4.59e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—IL6ST—epilepsy syndrome	4.31e-06	4.57e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—ALB—epilepsy syndrome	4.3e-06	4.56e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—POMC—epilepsy syndrome	3.94e-06	4.18e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CCL2—epilepsy syndrome	3.86e-06	4.09e-05	CbGpPWpGaD
L-Citrulline—NOS1—Disease—AKT1—epilepsy syndrome	3.86e-06	4.09e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—PTGS2—epilepsy syndrome	3.76e-06	3.99e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—SRC—epilepsy syndrome	3.63e-06	3.85e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—FGF2—epilepsy syndrome	3.49e-06	3.7e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—RELA—epilepsy syndrome	3.24e-06	3.43e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—MTOR—epilepsy syndrome	3.18e-06	3.37e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—CASP3—epilepsy syndrome	2.92e-06	3.1e-05	CbGpPWpGaD
L-Citrulline—NOS2—Disease—AKT1—epilepsy syndrome	2.91e-06	3.08e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—JUN—epilepsy syndrome	2.84e-06	3.01e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—MMP9—epilepsy syndrome	2.76e-06	2.93e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—SRC—epilepsy syndrome	2.54e-06	2.7e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—VEGFA—epilepsy syndrome	2.48e-06	2.63e-05	CbGpPWpGaD
L-Citrulline—NOS3—Disease—AKT1—epilepsy syndrome	2.26e-06	2.39e-05	CbGpPWpGaD
L-Citrulline—NOS3—Metabolism—AKT1—epilepsy syndrome	1.89e-06	2.01e-05	CbGpPWpGaD
L-Citrulline—NOS3—Signaling Pathways—AKT1—epilepsy syndrome	1.58e-06	1.68e-05	CbGpPWpGaD
